Bloomberg News
@Bloomberg-News·2.8M subscribers·40.1K videos
J&J Takes Over at Emergent Vaccine Plant With Aid From Biden
Posted
April 5, 2021
Views
508
Likes
7
Comments
1
Engagement
1.57%
April 5, 2021
508
7
1
1.57%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
0:48Now PlayingJohnson & Johnson, with help from the Biden administration, is taking over a Baltimore vaccine production facility that was the site of a major manufacturing error last month -- and moving production of material for a second company’s shot to minimize risk of another mistake.
J&J announced Saturday that it was “assuming full responsibility regarding the manufacturing of drug substance” at the Emergent BioSolutions Inc. plant. To facilitate that, the Department of Health and Human Services worked with AstraZeneca Plc. to move its production out of that plant so it can focus only on J&J, according to an HHS official familiar with the measure, who spoke on condition of anonymity.
Subscribe to our YouTube channel
Bloomberg Quicktake brings you live global news and original shows spanning business, technology, politics and culture. Make sense of the stories changing your business and your world.
To watch complete coverage on Bloomberg Quicktake 24/7, visit or watch on Apple TV, Roku, Samsung Smart TV, Fire TV and Android TV on the Bloomberg app.
Have a story to tell? Fill out this survey for a chance to have it featured on Bloomberg Quicktake
Connect with us on…
Breaking News on YouTube
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
